Compare Divis Laboratories with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES DISHMAN PHARMA DIVIS LABORATORIES/
DISHMAN PHARMA
 
P/E (TTM) x 40.3 30.0 134.4% View Chart
P/BV x 11.1 3.3 332.6% View Chart
Dividend Yield % 0.5 0.7 77.2%  

Financials

 DIVIS LABORATORIES   DISHMAN PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
DISHMAN PHARMA
Mar-16
DIVIS LABORATORIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,913374 1,045.1%   
Low Rs1,824129 1,415.2%   
Sales per share (Unadj.) Rs262.5197.0 133.3%  
Earnings per share (Unadj.) Rs74.721.2 352.8%  
Cash flow per share (Unadj.) Rs84.434.7 243.1%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Avg Dividend yield %0.70.8 87.7%  
Book value per share (Unadj.) Rs350.1179.9 194.7%  
Shares outstanding (eoy) m265.4780.70 329.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x10.91.3 855.4%   
Avg P/E ratio x38.411.9 323.2%  
P/CF ratio (eoy) x34.07.3 468.9%  
Price / Book Value ratio x8.21.4 585.6%  
Dividend payout %26.89.4 283.5%   
Avg Mkt Cap Rs m761,51720,307 3,749.9%   
No. of employees `000NANA-   
Total wages/salary Rs m8,2585,355 154.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m69,69415,898 438.4%  
Other income Rs m627265 236.1%   
Total revenues Rs m70,32116,163 435.1%   
Gross profit Rs m28,6114,103 697.3%  
Depreciation Rs m2,5561,091 234.4%   
Interest Rs m21944 2.2%   
Profit before tax Rs m26,6602,334 1,142.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,818624 1,093.2%   
Profit after tax Rs m19,8431,710 1,160.4%  
Gross profit margin %41.125.8 159.1%  
Effective tax rate %25.626.7 95.7%   
Net profit margin %28.510.8 264.7%  
BALANCE SHEET DATA
Current assets Rs m67,90611,018 616.3%   
Current liabilities Rs m17,2849,517 181.6%   
Net working cap to sales %72.69.4 769.4%  
Current ratio x3.91.2 339.4%  
Inventory Days Days1057 16.7%  
Debtors Days Days8783 25,105.1%  
Net fixed assets Rs m45,96318,787 244.6%   
Share capital Rs m531161 328.9%   
"Free" reserves Rs m92,41514,354 643.8%   
Net worth Rs m92,94614,516 640.3%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m113,86929,805 382.0%  
Interest coverage x1,270.53.5 36,604.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.5 114.7%   
Return on assets %17.48.9 195.9%  
Return on equity %21.311.8 181.2%  
Return on capital %28.717.5 163.8%  
Exports to sales %024.9 0.0%   
Imports to sales %18.83.7 503.8%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m13,127594 2,208.8%   
Fx inflow Rs m58,8774,952 1,189.1%   
Fx outflow Rs m13,341697 1,914.9%   
Net fx Rs m45,5364,255 1,070.2%   
CASH FLOW
From Operations Rs m19,4692,786 698.7%  
From Investments Rs m751-1,529 -49.1%  
From Financial Activity Rs m-349-941 37.1%  
Net Cashflow Rs m19,872317 6,278.6%  

Share Holding

Indian Promoters % 51.9 61.4 84.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.8 23.0 160.2%  
FIIs % 18.5 12.0 154.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 38.6 124.5%  
Shareholders   309,397 52,291 591.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


May 23, 2022 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS